Kraft Heinz (KHC) Q2 2026 earnings review
A $7.4 Billion Impairment Overshadows Slight Top-Line Relief
Kraft Heinz raised its top-line outlook, but that is where the good news ends. The company took a devastating $7.4 billion non-cash impairment charge on its intangible assets—following an almost identical $9.3 billion write-down exactly a year ago. Core operations are deteriorating: North American volume fell 3.8%, and Adjusted Operating Income plunged 18.4% as the company ramps up promotional 'investments' to $700 million to protect shelf space. Emerging Markets remain the lone bright spot, but they are entirely insufficient to mask the structural decay of the legacy U.S. portfolio.
🐂 Bull Case
The Emerging Markets segment grew Organic Net Sales by a robust 8.5%, driven by 4.0 percentage points of positive volume/mix. This segment continues to be the only dependable growth engine in the company.
Management increased the full-year Organic Net Sales guidance (now -0.5% to -2.0%). Strong free cash flow conversion (123%) ensures the dividend remains safe for now.
🐻 Bear Case
Writing down $7.4 billion in assets in 26Q2, after a $9.3 billion impairment in 25Q2, demonstrates that management and the market consistently overestimate the future cash-generating power of this legacy brand portfolio.
KHC is increasing its incremental investments by $100M to $700M. While this helped secure a top-line guidance bump, it forced a deceleration in the Constant Currency Adjusted Operating Income outlook (-16% to -18%). They are sacrificing margin to halt volume bleed.
⚖️ Verdict: 🔴🔴
Bearish. Two multi-billion dollar write-downs in 12 months is a glaring red flag. The North American core is shrinking, and the company is forced to aggressively spend margin to keep the top-line from accelerating its decline.
Key Themes
The Annual Multi-Billion Dollar Impairment Ritual
Reversing into a steep GAAP loss. KHC posted an operating loss of $6.4 billion in Q2, entirely driven by a $7.4 billion non-cash impairment loss on goodwill and intangible assets. This follows a $9.3 billion write-down in Q2 of the prior year. This signals severe, permanent impairment in the competitive positioning of its legacy brands.
North American Volume Bleed Continues
Stable, but consistently negative. North American Organic Net Sales fell 2.7%, heavily dragged down by a 3.8% decline in volume/mix. Despite previous quarters' claims of 'maniacal focus on execution' and investments into Power Mac & Cheese and Capri Sun, the domestic consumer is aggressively pushing back against the portfolio.
Margin Squeeze to Protect Shelf Space
Decelerating. Adjusted Operating Income plummeted 18.4% YoY to $1.04 billion. The company noted that increased advertising expenses, unfavorable volume/mix, and inflationary manufacturing/logistics costs outpaced efficiency initiatives. Management increased their 'incremental investment' war chest from $600M to $700M—a tacit admission that their brands cannot move off shelves without heavy promotional support.
Emerging Markets Resilience
Accelerating. While North America struggles, the Emerging Markets segment (representing 12% of total sales) posted 8.5% Organic Net Sales growth. Crucially, this was balanced growth: 4.5 points of price and 4.0 points of volume/mix. If KHC has any long-term structural growth story left, it resides entirely outside of the US and Europe.
Aggressive Working Capital Extraction
Stable. Despite collapsing operating income, KHC generated $2.1 billion in operating cash flow year-to-date (up 8.2%). This was achieved largely through extending payment terms (favorable accounts payable). This 123% Free Cash Flow conversion rate helps protect the dividend, though it cannot mask underlying operational decay forever.
Macro Pressures Squeeze the Core Consumer
The company's heavy exposure to the value-conscious consumer (including a previously noted 13% exposure to SNAP recipients) remains a major headwind. KHC explicitly cited shifts in Easter timing (~100 bps impact) and SNAP reduction headwinds as active suppressants to volume growth in the current quarter.
Product Superiority and Renovation
Management continues to funnel its $700M investment into product renovations like Lunchables, Philadelphia lactose-free, and Capri Sun Hydrate to drive trial. However, the 3.8% volume drop in North America suggests these innovations have not yet reached 'escape velocity' to offset broader portfolio declines.
Other KPIs
Decelerating. Down 18.8% YoY from $0.69, primarily driven by a sharp decline in Adjusted Operating Income which overwhelmed the benefit of lower adjusted tax rates.
Stable. Remained completely flat versus the prior year, indicating that the heavy 18.4% drop in Adjusted Operating Income was almost entirely driven by SG&A spikes (advertising, variable compensation) rather than pure COGS inflation.
Accelerating. Up 10.3% YoY from $1.50 billion. Capital expenditures remained perfectly flat ($429M vs $425M), meaning the entire FCF expansion came from squeezing working capital on the balance sheet.
Guidance
Accelerating. Management raised the outlook from the prior guide of -1.5% to -3.5%. This is the sole positive forward-looking metric, but it is explicitly being 'bought' via the $100M increase in marketing investments.
Decelerating. The top end of the range was lowered (prior was -14% to -18%). This implicitly confirms that the cost of halting the top-line decline is a deeper sacrifice of operating margins.
Stable vs prior expectations, but Decelerating severely YoY. The midpoint of $2.06 represents a ~20.7% contraction from FY25's Adjusted EPS of $2.60. The guide was tweaked slightly upward from the prior $1.98-$2.10 range due to favorable lower interest expense expectations.
Key Questions
Impairment Anatomy
You've written down almost $16.7 billion in intangible assets over the last 12 months. Specifically which brands drove the $7.4 billion impairment this quarter, and at what point do you believe the carrying value of the North American portfolio is finally stabilized?
Return on Incremental Investment
You increased incremental investments by $100 million to $700 million, which narrowed your Operating Income guidance downward. What specific volume/mix inflection metrics are you demanding internally to justify these margin-dilutive investments?
Emerging Markets Sustainability
Emerging Markets generated excellent 8.5% organic growth with strong volume. Given the severe struggles in North America, are there plans to disproportionately reallocate capital allocation or M&A focus toward scaling the Emerging Markets infrastructure?
Pricing Power Fatigue
Price realization in North America was only +1.1%, failing to offset the -3.8% volume drop. Have we reached the absolute ceiling for pricing power in your domestic grocery portfolio?